Jamie Schwarzbach

Chemist turned marketer that dabbles in cycling, snowboarding, and traveling. Currently @nateraoncology, previously @twistbioscience. Opinions my own.

[Octave @OctaveBio]

Thrilled to share the Proteomics Clinical Applications May 2023 cover is based on our publication: "Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis" by Octave's Ferhan Qureshi et al.

https://t.co/MgrhvmBa4D

[Octave @OctaveBio]

Octave's Multiple Sclerosis Disease Activity (MSDA) Test was analytically validated, demonstrating a high level of accuracy, sensitivity, precision & robustness.

Read the study validating this minimally invasive tool to improve MS management:
https://t.co/Snsyoc3DK9

[Breast Cancer Canada @BreastCancerCDN]

BCC was excited to meet up with industry leader @NateraGenetics last week at the @SABCSSanAntonio.

Natera focuses on evaluation of cancer cells remaining in the body after primary treatment of cancer, called molecular residual disease (MRD).

[Colorectal Cancer Alliance @CCAlliance]

“If you’re not a cancer patient, you don’t understand the psychological burden of it coming back,” survivor @brooksbell said. “It’s a horrible burden." Fortunately, her doctor had a solution to help put her at ease.

Thanks to sponsor @NateraOncology.
https://t.co/6bEIcoT66T

[AIM at Melanoma Foundation @AIMatMelanoma]

Circulating tumor DNA (ctDNA) is an emerging biomarker in melanoma. Dr. Andrew S. Poklepovic shares more on these tests, including how they work, their current limitations, and the hope for their future.
REGISTER: https://t.co/DQms4zJaPD

[Natera Oncology @NateraOncology]

For people with #BreastCancer, #Natera's Signatera Residual Disease Test can be used to help identify recurrence earlier than traditional tools. #Signatera looks for circulating tumor DNA (#ctDNA) and is custom designed for each person. https://t.co/HX1kiAuF7b #CancerAwareness

[Fight Colorectal Cancer @FightCRC]

‼ BIG NEWS ‼ On July 25, the @WHOSTP will be hosting #FightCRC and a group of #ColorectalCancer patient advocacy and business leaders who we have convened to discuss ways we can work together to improve and increase access to CRC screening. #MyCancerMoonshot #CancerMoonshot

[Fight Colorectal Cancer @FightCRC]

“My goal is to finish the hike and raise as much money as possible while informing people #colorectalcancer isn’t an old man’s cancer anymore.” -@JJSingleton1 @mountaineerinfo

To read the full article and learn more about Climb for a Cure: ⬇️⬇️
https://t.co/BzR1KMtLb6

[Natera Oncology @NateraOncology]

The latest data around #Signatera further supports its capabilities to detect #MRD and treatment response monitoring.

We’re excited to share details about our research at @ASCO’s Annual Meeting. #ASCO22

More below. 👇
https://t.co/QqvprB2RAl

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

We're grateful for @NateraOncology's support of our Conquer Cancer mission! If you're at #ASCO22, join them at booth 6117 to record a short video interview about #oncology #innovation in 2022 - they'll donate to us if you do!

[Philz Coffee @PhilzCoffee]

In honor of International Coffee Day this Friday, we’re giving away a $50 In-Store Gift Card AND a Philz In a Box Cold Brew to 3 lucky winners! Just Follow, Like, Retweet this post and tag a friend for a chance to win! Winners announced this FRIDAY. Good luck! #PhilzCoffeeWeek

[Philz Coffee @PhilzCoffee]

Celebrating back to school, work, and life; we're giving away $25 Dollar Gift Cards every week in September to 3 winners who could use some Philz to "Phuel" themselves this Fall! Just Follow, Like, and retweet this message and we'll announce winners on Fridays. Happy Tuesday!

[Jamie Schwarzbach @JLSchwarzbach]

We're hiring! This is just one of the many #biostatistician jobs available at Natera. Shoot me a message if you're interested in joining a growing company with great people and impressive benefits. #hiring #jobs #nowhiring #recruiting https://t.co/1u5SNpLlBF #jobopening #applynow

[Natera Oncology @NateraOncology]

Do you have an interesting research proposal using the Signatera MRD assay?

Natera welcomes all US clinicians to submit applications for our Signatera Research Fund this year. Learn more: https://t.co/JOoK9iQBhx

#oncology #oncologyresearch #cancerresearch

[Good Morning America @GMA]

This new potential cancer breakthrough could detect tumor reoccurrence up to two years before scans.
https://t.co/f2tBpzsWTL

[Alan Burguete-Torres M.D. @dralanburguete]

Who said romance is dead?

[Colorectal Cancer Alliance @CCAlliance]

IT’S OFFICIAL: Colorectal cancer screening should begin at age 45 for people at average risk!

We celebrate this major milestone in our mission to end colorectal cancer. The guidelines released today by the U.S. Preventive Services Task Force will save thousands of lives.

[honeyritual @honeyritual]

We'd like to give a shout-out to our founders. Learn more about how the three of them got together to create a product that brings us closer together and more in tune with ourselves. #honeyritual #hotteatonic #health #wellness #mentalhealth
https://t.co/WwtAHao4ZW

[Natera Oncology @NateraOncology]

Join us this Thursday for an intimate discussion about #ctDNA testing and how this technology is revolutionizing treatment decisions in #melanoma and other cutaneous cancers during our breakout session at the 10th World congress of Melanoma!

RSVP now: https://t.co/w2YDH0cQbt

[Jamie Schwarzbach @JLSchwarzbach]

@seescandies Hands down, Dark Butterchew. 🤤
#CandyConversations